|
Over the past 25 years, the UN Convention on Biological Diversity (CBD) has established a system of global oversight for living (a.k.a. genetically) modified organisms (LMOs) based on the principles of precaution, fairness (equitable sharing of benefits) and prior informed consent. COP 14 and COP-MOP 9 will be key to upholding those principles and ensuring they are extended to the governance of next-generation genetic engineering technologies: i.e., synthetic biology, which increasingly encompasses genome editing and gene drive technologies. […]
Critique of African Union report endorsing the development of controversial gene drive mosquitoes for malaria ‘eradication’ in Africa and ‘enabling legislation’ for their deployment across its member states. […]
A growing body of scientific studies highlights the risks and unintended consequences from the use of new genetic engineering techniques such as gene editing in agriculture. […]
A new study has found that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought, creating safety implications for gene therapies using CRISPR/Cas9. […]
This report explores the urgent need for a global governance framework for gene drive, given the technology’s powerful implications for wild species and ecosystems. It identifies principles and essential elements for such a framework. […]
The EU Court of Justice has ruled that organisms obtained by the new generation of gene editing techniques are GMOs and are subject to the obligations laid down by GM regulations of the EU. […]
Parties to the Convention on Biological Diversity (CBD), at a subsidiary meeting, have called for precaution when addressing organisms containing engineered gene drives. […]
New informational materials about the important emerging area of synthetic biology and associated topic of digital sequence information on genetic resources are now available at www.synbiogovernance.org […]
This study found that using CRISPR-Cas9 to engineer resistance to geminiviruses in cassava resulted in the emergence of a CRISPR-resistant mutant virus, highlighting the potential for CRISPR-systems to trigger the evolution of new viruses. […]
A report by the Swiss Federal Ethics Committee on Non-Human Biotechnology shows that the precautionary principle and the precautionary measures to which it gives rise can be justified ethically with respect to regulating new biotechnologies. […]
|
|